Abstract
Folate receptor β (FR-β) expression may serve as a marker of activated macrophages involved in autoimmune myocarditis. The positron emission tomography (PET) tracer N-succinimidyl 4-[ 18F]fluorobenzoate-conjugated folate ([ 18F]SFB-FOL) effectively targets FR-β-positive macrophages in rheumatoid arthritis. Here, we examined [ 18F]SFB-FOL for detecting myocardial inflammation via FR-β in a rat model of experimental autoimmune myocarditis (EAM), in comparison with the established FR-β-targeted PET tracer aluminum fluoride-18-labeled 1,4,7-triazacyclononane-1,4,7-triacetic acid-conjugated folate ([ 18F]FOL). EAM was induced in 22 Lewis rats through cardiac myosin immunization. Rats underwent 2-deoxy-2-[ 18F]fluoro-d-glucose ([ 18F]FDG) PET to visualize myocardium, followed by dynamic PET with [ 18F]SFB-FOL or [ 18F]FOL at Days 14, 21, or 28 postimmunization. Postimaging, myocardial tissues were assessed by γ-counting, autoradiography, and CD68 immunohistochemistry to quantify macrophage presence. Both tracers showed high radiochemical purity and in vivo stability. Inflammation-rich myocardial lesions were confirmed, with macrophages occupying 9.9% ± 1.1 of the tissue area. PET imaging revealed significantly higher uptake of both tracers in inflamed myocardium versus remote areas, confirmed by histology and autoradiography. Lesion-to-remote uptake ratios were 5.7 ± 1.8 for [ 18F]SFB-FOL and 3.8 ± 0.5 for [ 18F]FOL. Blood clearance and renal excretion were rapid for both tracers. No significant differences were observed in tracer uptake or macrophage density between Days 21 and 28. [ 18F]SFB-FOL is a suitable tracer for detecting active myocardial inflammation via FR-β in EAM and performs comparably to [ 18F]FOL.
| Original language | English |
|---|---|
| Pages (from-to) | 3453-3462 |
| Number of pages | 10 |
| Journal | ACS Pharmacology and Translational Science |
| Volume | 8 |
| Issue number | 10 |
| DOIs | |
| Publication status | Published - 10 Oct 2025 |
| MoE publication type | A1 Journal article-refereed |
Funding
The study was supported financially by grants from the Jane and Aatos Erkko Foundation, the Sigrid Jusélius Foundation, the Finnish Foundation for Cardiovascular Research, the Research Council of Finland (#350117, #343152), and the Turku University Foundation. E.A.H. is a PhD student supported in part by the Drug Research Doctoral Programme of the University of Turku Graduate School and by the doctoral module of the InFLAMES Flagship.
Keywords
- Pet
- Experimental autoimmune myocarditis
- Folate
- Folate receptor beta
- Myocarditis